PMID: 6107107Jan 1, 1980Paper

The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study

British Journal of Anaesthesia
S AgostonW Erdmann

Abstract

The neuromuscular blocking effects of the new monoquaternary analogue of pancuronium, Org NC 45, have been investigated in anaesthetized patients. In different doses administered as a single i.v. bolus or as an initial bolus followed by several small maintenance doses or by a continuous infusion. Org NC 45 appears to be approximately as potent as pancuronium, but has a more rapid onset of action, considerably shorter duration of action and faster recovery rate than pancuronium. It showed no cumulative effects even after 10 maintenance doses were injected in succession. Doses of 0.08 mg kg-1 provided ideal intubating conditions in 90--95 s. Infusions of Org NC 45 provided much smoother control of neuromuscular blockade than did pancuronium. No cardiovascular side-effects were noted even at the greatest dose (0.12 mg kg-1) used. Org NC 45 has clear advantages over pancuronium and represents a potentially valuable addition to the armamentarium of clinically useful muscle relaxants.

Citations

Jan 1, 1983·European Journal of Clinical Pharmacology·A A d'HollanderJ M Desmonts
Nov 1, 1982·Canadian Anaesthetists' Society Journal·A WilliamsD R Bevan
Mar 1, 1983·Canadian Anaesthetists' Society Journal·H GyasiD R Beran
May 1, 1986·Canadian Anaesthetists' Society Journal·J J Savarese
Mar 1, 1988·Journal of Anesthesia·H ObaraS Iwai
Jun 24, 2000·Anaesthesia·A G McKenzie
Jul 1, 1991·Acta Anaesthesiologica Scandinavica·L I ErikssonC Lennmarken
Aug 1, 1984·Journal of Pharmacological Methods·R Hughes
Sep 1, 1992·Anaesthesia·I T HoughtonT E Oh
Oct 1, 1983·British Journal of Anaesthesia·F A Rosewarne
Sep 1, 1981·Anaesthesia·P Harrison, S A Feldman
Feb 1, 1989·Anaesthesia·D Northwood
Jul 1, 1985·Acta Anaesthesiologica Scandinavica·J EngbaekJ Viby-Mogensen
Mar 7, 2002·British Journal of Anaesthesia·E W Moore, J M Hunter
Jun 1, 1981·Acta Anaesthesiologica Scandinavica·R L Sia, O M Rashkovsky
Dec 1, 1983·Acta Anaesthesiologica Scandinavica·R K MirakhurT D Lavery
May 1, 1989·Acta Anaesthesiologica Scandinavica·G H HackettG Earnshaw
May 1, 1985·Acta Anaesthesiologica Scandinavica·K G LowryR S Clarke
Sep 1, 1996·European Journal of Anaesthesiology·F K PühringerA Benzer
Mar 1, 1988·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·H NagashimaF F Foldes
Aug 24, 2017·Critical Care Nursing Quarterly·Keaton S SmetanaG Morgan Jones
Apr 1, 1997·The Journal of Pharmacy and Pharmacology·J M Midgley, J B Stenlake
Sep 1, 1984·Drug Intelligence & Clinical Pharmacy·C S Conner
Dec 1, 1984·British Journal of Clinical Pharmacology·C J FerresF M Gibson
May 1, 1982·Anaesthesia and Intensive Care·T A Torda, N Kiloh
Jan 1, 1991·DICP : the Annals of Pharmacotherapy·G E LarijaniA G Jacobi
Sep 23, 1998·Anaesthesia and Intensive Care·S SinhaA Bhattacharya
Sep 1, 1995·Journal of Anesthesia·Kouichiro MinamiAkio Shigematsu
Oct 1, 1983·Anaesthesia·C J FerresR K Mirakhur

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.